Skip to content

Effects of FRAX+SARC-F Pre-screening on Preventing Fragility Fracture and Fall in Community-dwelling Older Adults

The Effects of FRAX+SARC-F Questionnaire Pre-screening on Promoting Public Awareness of Fragility Fracture and Fall Prevention Among Community-dwelling Older Adults

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04709393
Enrollment
2956
Registered
2021-01-14
Start date
2021-05-07
Completion date
2028-12-31
Last updated
2024-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age Related Osteoporosis, Fall

Brief summary

Hip fragility fractures are a major threat to functional independence in older adults locally and globally. In Hong Kong, the prevalence of osteoporosis and osteopenia in people aged \>50 years were reported to be as high as 37% and 52%, respectively. The major challenge in fragility fracture prevention is that fragility fracture is caused by the combination of osteoporosis and propensity to fall, and both of these conditions are multifactorial. Ample evidence shows that fall risks can be reduced by well-designed exercises, and osteoporosis can be effectively diagnosed by Dual-energy X-ray Absorptiometry imaging (DXA) and treated with anti-osteoporosis medication. Lifestyle modifications e.g. diet, optimal physical activity, environmental safety can also help to prevent falls or improve bone health. The brief Fracture Risk Assessment Tool (FRAX) and SARC-F provide a low cost of prescreening for fracture risk and sarcopenia, respectively. Using SARC-F in conjunction with FRAX has increased sensitivity for hip fracture risk prediction. FRAX+SARC-F may help increase the public awareness of osteoporosis and get the at-risk group to receive diagnostic tests and be treated. This model should fit in well with the coming District Health Centres across Hong Kong.

Detailed description

Participants will be randomly assigned to either the pre-screening or control group in a 1:1 ratio. Independent personnel not involved in data collection or intervention will perform and conceal the randomization using an online data server. Research assistants who are blinded to the group allocation will conduct all the baseline assessments and subsequent event surveillance. All data will also be entered and checked by the blinded research assistants. All procedures concur with the Declaration of Helsinki (2013).

Interventions

OTHERFRAX+SARC-F questionnaire pre-screening

Pre-screening group participants will receive the FRAX+SARC-F questionnaire pre-screening and be notified of the preliminary estimation of their future hip fracture risk before being invited to our DXA screening and fall-risk assessment.

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* aged ≥ 65 years * living in the community

Exclusion criteria

• cannot follow the instruction

Design outcomes

Primary

MeasureTime frameDescription
proportions of participants diagnosed with osteoporosis in the FRAX+SARC-F pre-screening and control groups.within 1-6 monthsproportions of participants diagnosed with osteoporosis in the FRAX+SARC-F pre-screening and control groups.

Secondary

MeasureTime frameDescription
rate of receiving fall risk assessment6-12 monthsNumber of participants receiving fall risk assessment in the arms
rate of receiving anti-osteoporosis intervention6-12 monthsNumber of participants receiving anti-osteoporosis intervention in the arms
Rate of receiving osteoporosis screening6-12 monthsNumber of participants receiving osteoporosis screening in the arms
subsequent fall rate12 monthsNumber of participants having subsequent fall in the arms
subsequent fracture rate12 monthsNumber of participants having subsequent fracture in the arms
rate of receiving fall prevention intervention6-12 monthsNumber of participants receiving fall prevention intervention in the arms

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026